Opportunity
SAM #36C24426Q0756
Sole Source 5-Year IDIQ for Clinical Laboratory Automation and Middleware at Wilkes-Barre VA Medical Center
Buyer
VA NCO 4
Posted
July 02, 2026
Respond By
July 08, 2026
Identifier
36C24426Q0756
NAICS
334516, 423450, 621511, 423490
This notice announces the Department of Veterans Affairs' intent to award a sole source, 5-year IDIQ contract to Beckman Coulter, LLC for clinical laboratory instrumentation, reagents, supplies, and services at the Wilkes-Barre VA Medical Center. - Contract covers Chemistry, Immunochemistry, Chemiluminescent, and Hematology testing on an automated line with auto-verification. - Includes 2 primary chemistry analyzers, 2 primary immunochemistry analyzers, 2 mirror image hematology analyzers, a reflex analyzer, slide maker stainer, and middleware software (Remisol Advance). - Automation line must handle all tube sizes/types, have refrigerated stockyard for at least 10,000 samples, and support specimen retrieval, tracking, and auto-verification. - Software requirements include compatibility with Remisol Advance and Data Innovations Instrument Manager wrapper rules. - Estimated annual test volumes for key analytes (e.g., Glucose: 61,471; BUN: 61,603; Creatinine: 111,285). - Services include installation, training (including off-site), preventative maintenance, emergency repair (2-hour onsite response), and hardware/software upgrades. - Sole source justification is based on compatibility with existing auto-verification software and custom rule maintenance. - Period of performance is 5 years, with a 90-day implementation/transition period post-award for installation and training. - Potential competitors include other major clinical laboratory OEMs capable of providing similar automated solutions and middleware integration.
Technical and business highlights: - Beckman Coulter, LLC is the sole source vendor due to software and instrument compatibility requirements. - Remisol Advance and Data Innovations are key middleware/software components. - The procurement includes both equipment and ongoing support services. - Estimated contract value likely ranges from $2,000,000 to $5,000,000 over 5 years, based on scope and industry standards. - Commercial opportunity is limited due to sole source justification, but similar OEMs may be considered for future requirements if compatibility is addressed.
Description
This request is for the instrumentation, reagents supplies and services to perform Clinical Laboratory Chemistry, Immunochemistry, Chemiluminescent and Hematology Testing on an automation line with auto-verification. Must support the current auto verification software in use at the WBVAMC which requires maintaining and adding rules for both the Remisol Advance software and Data Innovations Instrument Manager wrapper rules for the current instruments.